Influence of fixed-dose combination perindopril/amlodipine on target organ damage in patients with arterial hypertension with and without ischemic heart disease (results of EPHES trial)

References

• MoserMHebertPRPrevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trialsJ Am Coll Cardiol1996275121412188609345
   PubMed Web of Science ®Google Scholar
• PalmieriVDahlöfBDequattroVReliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE study. Prospective Randomized Study Evaluating Regression of Ventricular EnlargementJ Am Coll Cardiol19993451625163210551715
   PubMed Web of Science ®Google Scholar
• ManciaGCarugoSGrassiGPrevalence of Left Ventricular Hypertrophy in Hypertensive Patients Without and With Blood Pressure Control: Data From the PAMELA PopulationHypertension200239374474911897756
   PubMed Web of Science ®Google Scholar
• EpsteinMTobeSWhat is the optimal strategy to intensify blood pressure control and prevent progression of renal failure?Curr Hypertens Rep20013542242811551378
   PubMedGoogle Scholar
• KlagMJWheltonPKRandallBLBlood pressure and end-stage renal disease in menN Engl J Med1996334113187494564
   PubMed Web of Science ®Google Scholar
• SmulyanHLieberASafarMEHypertension, Diabetes Type II, and Their Association: Role of Arterial StiffnessAm J Hypertens201629151326156872
   PubMed Web of Science ®Google Scholar
• DevereuxRBWachtellKGerdtsEPrognostic significance of left ventricular mass change during treatment of hypertensionJAMA2004292192350235615547162
   PubMed Web of Science ®Google Scholar
• IbsenHOlsenMHWachtellKReduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension studyHypertension200545219820215655123
   PubMed Web of Science ®Google Scholar
• PatelAADVANCE Collaborative GroupMacMahonSEffects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trialLancet2007370959082984017765963
   PubMed Web of Science ®Google Scholar
• DeloachSSTownsendRRVascular stiffness: its measurement and significance for epidemiologic and outcome studiesClin J Am Soc Nephrol20083118419218178784
   PubMed Web of Science ®Google Scholar
• RitzEMenneJHallerHHPrevalence of microalbuminuria in type 2 diabetes: lessons learned from the ROADMAP studyNephrol Dial Transplant201227Suppl 4283022287699
   PubMedGoogle Scholar
• ManciaGFagardRNarkiewiczKTask Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertension201331712811357
   PubMed Web of Science ®Google Scholar
• YusufSHawkenSOunpuuSEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyLancet2004364943893795215364185
   PubMed Web of Science ®Google Scholar
• Prospective Studies CollaborationWhitlockGLewingtonSBody-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studiesLancet200937396691083109619299006
   PubMed Web of Science ®Google Scholar
• Guidelines of Ukrainian Association of CardiologistDyslipidemia: diagnosis, prevention and treatmentKyiv201149
   Google Scholar
• KarioKMorning surge in blood pressure and cardiovascular risk: evidence and perspectivesHypertension201056576577320937968
   PubMed Web of Science ®Google Scholar
• LeveyAStevensLSchmidCCKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rateAnn Intern Med2009150960461219414839
   PubMed Web of Science ®Google Scholar
• SteinJHKorcarzCEHurstRTUse of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular MedicineJ Am Soc Echocardiogr20082129311118261694
   PubMed Web of Science ®Google Scholar
• FoppaMDuncanBBRohdeLEEchocardiography-based left ventricular mass estimation. How should we define hypertrophy?Cardiovasc Ultrasound200531715963236
   PubMedGoogle Scholar
• LenterCGeigy Scientific TablesBaselCIBA-GEIGY Corporation1990278
   Google Scholar
• ParatiGLantelmePBlood pressure variability, target organ damage and cardiovascular eventsJ Hypertens20022091725172912195111
   PubMed Web of Science ®Google Scholar
• MiaoCYSuDFThe importance of blood pressure variability in rat aortic and left ventricular hypertrophy produced by sinoaortic denervationJ Hypertens20022091865187212195130
   PubMed Web of Science ®Google Scholar
• MiaoCYXieHHZhanLSSuDFBlood pressure variability is more important than blood pressure level in determination of end-organ damage in ratsJ Hypertens20062461125113516685213
   PubMed Web of Science ®Google Scholar
• FluesKMoraes-SilvaICMostardaCCardiac and pulmonary arterial remodeling after sinoaortic denervation in normotensive ratsAutonomic Neuroscience20121661-2475322079748
   PubMed Web of Science ®Google Scholar
• SuDFMiaoCYBlood pressure variability and organ damageClin Exp Pharmacol Physiol200128970971511553028
   PubMed Web of Science ®Google Scholar
• ParatiGPomidossiGAlbiniFMalaspinaDManciaGRelationship of 24-hour blood pressure mean and variability to severity of target-organ damage in hypertensionJ Hypertens19875193983584967
   PubMed Web of Science ®Google Scholar
• FrattolaAParatiGCuspidiCAlbiniFManciaGPrognostic value of 24-hour blood pressure variabilityJ Hypertens19931110113311378258679
   PubMed Web of Science ®Google Scholar
• ManciaGParatiGHennigMRelation between blood pressure variability and carotid artery damage in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis (ELSA)J Hypertens200119111981198911677363
   PubMed Web of Science ®Google Scholar
• SegaRCorraoGBombelliMBmetAlBlood pressure variability and organ damage in a general population: results from the PAMELA studyHypertension200239271071411882636
   PubMed Web of Science ®Google Scholar
• SanderDKuklaCKlingelhöferJWinbeckKConradBRelationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up studyCirculation2000102131536154111004145
   PubMed Web of Science ®Google Scholar
• McmullanCJBakrisGLPhillipsRAFormanJPAssociation of BP variability with mortality among African Americans with CKDClin J Am Soc Nephrol20138573173823493382
   PubMed Web of Science ®Google Scholar
• FukuiMUshigomeETanakaMHome blood pressure variability on one occasion is a novel factor associated with arterial stiffness in patients with type 2 diabetesHypertens Res201336321922523096230
   PubMed Web of Science ®Google Scholar
• García-GarcíaÁGarcía-OrtizLRecio-RodríguezJIRelationship of 24-h blood pressure variability with vascular structure and function in hypertensive patientsBlood Press Monit201318210110623388405
   PubMed Web of Science ®Google Scholar
• KawaiTOhishiMKamideKDifferences between daytime and nighttime blood pressure variability regarding systemic atherosclerotic change and renal functionHypertens Res201336323223923076404
   PubMed Web of Science ®Google Scholar
• CaySCagirciGDemirADAmbulatory blood pressure variability is associated with restenosis after percutaneous coronary intervention in normotensive patientsAtherosclerosis2011219295195722005197
   PubMed Web of Science ®Google Scholar
• OzawaMTamuraKOkanoYIdentification of an increased short-term blood pressure variability on ambulatory blood pressure monitoring as a coronary risk factor in diabetic hypertensivesClin Exp Hypertens200931325927019387902
   PubMed Web of Science ®Google Scholar
• SakakuraKIshikawaJOkunoMShimadaKKarioKExaggerated ambulatory blood pressure variability is associated with cognitive dysfunction in the very elderly and quality of life in the younger elderlyAm J Hypertens200720772072717586405
   PubMed Web of Science ®Google Scholar
• IwataSJinZSchwartzJERelationship between ambulatory blood pressure and aortic arch atherosclerosisAtherosclerosis2012221242743122296886
   PubMed Web of Science ®Google Scholar
• SchillaciGBiloGPucciGRelationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databasesHypertension201260236937722753222
   PubMed Web of Science ®Google Scholar
• SchutteAESchutteRHuismanHWBlood pressure variability is significantly associated with ECG left ventricular mass in normotensive Africans: the SABPA StudyHypertens Res201134101127113421796132
   PubMed Web of Science ®Google Scholar
• RothwellPMHowardSCDolanEPrognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertensionLancet2010375971889590520226988
   PubMed Web of Science ®Google Scholar
• CuffeRLRothwellPMMedium-term variability in systolic blood pressure is an independent predictor of strokeCerebrovasc Dis200519Suppl 25112
   Google Scholar
• RothwellPMLimitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertensionLancet2010375971893894820226991
   PubMed Web of Science ®Google Scholar
• WebbAJFischerUMehtaZRothwellPMEffects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysisLancet2010375971890691520226989
   PubMed Web of Science ®Google Scholar
• ZhangYAgnolettiDSafarMEBlacherJEffect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) studyHypertension201158215516021747047
   PubMed Web of Science ®Google Scholar
• RothwellPMHowardSCDolanEEffects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of strokeLancet Neurol20109546948020227347
   PubMed Web of Science ®Google Scholar
• WilliamsBLacyPfor the CAFE and the ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) Investigators Impact of Heart Rate on Central Aortic Pressures and Hemodynamics Analysis From the CAFE (Conduit ArteryFunction Evaluation) Study: CAFE-Heart RateJ Am CollCardiol200954705713
   Google Scholar
• BoutouyriePTropeanoAIAsmarRAortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal studyHypertension2002391101511799071
   PubMed Web of Science ®Google Scholar
• BoutouyriePAchoubaATrunetPLaurentSEXPLOR Trialist GroupAmlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR studyHypertension20105561314132220404219
   PubMed Web of Science ®Google Scholar
• MatsuiYEguchiKO’RourkeMFO’RourkeMDifferential effects between a calcium channel blocker and a diuretic when used in combination with angiotensin II receptor blocker on central aortic pressure in hypertensive patientsHypertension200954471672319667251
   PubMed Web of Science ®Google Scholar
• ShevelevaOTarget organ damage in patients with arterial hypertension and ischemic heart disease, who live in Priobye Thesis of Candidate of Medical Science Available from: http://medical-diss.com/medicina/porazhenie-organov-misheney-u-bolnyh-arterialnoy-gipertoniey-v-sochetanii-s-ibs-prozhivayuschih-v-srednem-priobie
   Google Scholar
• KamberiLSBedri BakalliAMuhamet BudimaNBudimaNMPleiotropic and Lipid-lowering Effects of Statins in HypertensionMater Sociomed2012242848623678313
   PubMedGoogle Scholar
• LarosaJCGrundySMWatersDDIntensive lipid lowering with atorvastatin in patients with stable coronary diseaseN Engl J Med2005352141425143515755765
   PubMed Web of Science ®Google Scholar
• NissenSETuzcuEMSchoenhagenPEffect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trialJAMA200429191071108014996776
   PubMed Web of Science ®Google Scholar
• SeverPDahlöfBPoulterNPotential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes TrialEur Heart J200627242982298817145722
   PubMed Web of Science ®Google Scholar
• MasonRPWalterMFDayCAJacobRFIntermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actionsAm J Cardiol2005965A1123
   PubMed Web of Science ®Google Scholar
• MunroEPatelMChanPInhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesisEur J Clin Invest199424117667727890015
   PubMed Web of Science ®Google Scholar
• SipahiITuzcuEMSchoenhagenPEffects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosisJ Am Coll Cardiol200648483383816904557
   PubMed Web of Science ®Google Scholar
• AriffBZambaniniAVamadevaSCandesartan- and Atenolol-Based Treatments Induce Different Patterns of Carotid Artery and Left Ventricular Remodeling in HypertensionStroke20063792381238416888272
   PubMed Web of Science ®Google Scholar
• OlsenMHWachtellKNelandKLosartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudyBlood Press200514317718316036498
   PubMed Web of Science ®Google Scholar
• AZMGBMHCalcium Antagonist Lacidipine Slows Down Progression of Asymptomatic Carotid Atherosclerosis Principal Results of the European Lacidipine Study on Atherosclerosis (ELSA), a Randomized, Double-Blind, Long-Term TrialCirculation20021062422242712417537
   PubMed Web of Science ®Google Scholar
• KlauseOStumpeKEA-RTZCarotid intima-media thickness and plaque volume changes following 2-year angiotensin II-receptor blockade. The Multicentre Olmesartan atherosclerosis Regression Evaluation (MORE) studyTher Adv Cardiovasc Dis2007129710619124398
   PubMedGoogle Scholar
• MigrinoRQBowersMHarmannLProstRLadisaJFCarotid plaque regression following 6-month statin therapy assessed by 3T cardiovascular magnetic resonance: comparison with ultrasound intima media thicknessJ Cardiovasc Magn Reson20111313721812992
   PubMedGoogle Scholar
• MottramPMRelation of arterial stiffness to diastolic dysfunction in hypertensive heart diseaseHeart200591121551155616287739
   PubMed Web of Science ®Google Scholar
• DaemenJDiastolic dysfunction and arterial stiffness: the chicken or the eggNeth Heart J201321521922123553539
   PubMed Web of Science ®Google Scholar
• BarronAJHughesADSharpALong-Term Antihypertensive Treatment Fails to Improve E/E Despite Regression of Left Ventricular Mass: An Anglo-Scandinavian Cardiac Outcomes Trial SubstudyHypertension201463225225824218432
   PubMed Web of Science ®Google Scholar